null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Lung Cancer (Translational and Emerging Therapies)

List Price: $55.99
SKU:
9780367453091
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Kishan J. Pandya, Julie R. Brahmer, Manuel Hidalgo
    Format:
    Paperback
    Pages:
    278
    Publisher:
    CRC Press (June 30, 2020)
    Language:
    English
    ISBN-13:
    9780367453091
    Weight:
    16.25oz
    Dimensions:
    6" x 9"
    File:
    TAYLORFRANCIS-TayFran_260406043133783-20260406.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $55.99
    Case Pack:
    20
    As low as:
    $53.19
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Country of Origin:
    United States
    Pub Discount:
    30
    Imprint:
    CRC Press
  • Overview

    Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy, to stand at the forefront of technologies for patient diagnosis and treatment.